Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Mario I Vega, PhD, Yijiang Shi, MD PhD, Patrick Frost, PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD

Blood (2019) 134 (Supplement_1): 1821.

https://doi.org/10.1182/blood-2019-121480

Published: 2019

Journal Articles

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

Mario Vega, PhD, Patrick Frost, PhD, Carolyne Bardeleben, PhD, Yijiang Shi, MD PhD, Sara Huerta-Yepez, PhD, Alan Lichtenstein, MD

Blood (2017) 130 (Supplement 1): 3833.

https://doi.org/10.1182/blood.V130.Suppl_1.3833.3833

Published: 2017

Journal Articles

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

Patrick J. Frost, PhD, YiJiang Shi, MD, Carolyne Bardalaban, PhD, Bao Hoang, PhD, Alan Lichtenstein, MD

Blood (2007) 110 (11): 4795.

https://doi.org/10.1182/blood.V110.11.4795.4795

Published: 2007

Journal Articles

AKT Kinase Addiction in Multiple Myeloma.

Carolyne Bardeleben, PhD, Huajun Yan, PhD, Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, PhD, Sanjai Sharma, MD, Alan Lichtenstein, MD

Blood (2006) 108 (11): 3431.

https://doi.org/10.1182/blood.V108.11.3431.3431

Published: 2006

Journal Articles

Anti-Angiongenic Effects of mTOR-Inhibitors Is Regulated by AKT Activity in Multiple Myeloma Cells.

Patrick Frost, PhD, Bao Hoang, PhD, Yijiang Shi, MD, Huajun Yan, PhD, Alan Lichtenstein, MD

Blood (2005) 106 (11): 3406.

https://doi.org/10.1182/blood.V106.11.3406.3406

Published: 2005

Journal Articles

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Huajun Yan, PhD, Patrick Frost, PhD, Yijiang Shi, MD & PhD, Bao Hoang, PhD, Sanjai Sharma, MD, Myrna Fisher, Joseph Gera, PhD, Alan Lichtenstein, MD

Blood (2005) 106 (11): 1582.

https://doi.org/10.1182/blood.V106.11.1582.1582

Published: 2005

NARROW

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

AKT Kinase Addiction in Multiple Myeloma.

Anti-Angiongenic Effects of mTOR-Inhibitors Is Regulated by AKT Activity in Multiple Myeloma Cells.

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Email alerts

ASH Publications

American Society of Hematology

A Deptor Inhibitor Induces Its Degradation with Resulting Anti-Myeloma Cytotoxicity in Vitro and In Vivo

Deptor As a Target with Chemical Inhibitors; Alternative Therapy in Multiple Myeloma

The Role of AKT and ERK in Regulating D-Cyclin Translation Inhibition and G1 Arrest in Multiple Myeloma Cells Treated with mTOR Inhibitors: Rationale for Combination Thereapy.

AKT Kinase Addiction in Multiple Myeloma.

Anti-Angiongenic Effects of mTOR-Inhibitors Is Regulated by AKT Activity in Multiple Myeloma Cells.

Mechanism by Which mTOR Inhibitors Sesitize Multiple Myeloma Cells to Dexamethasone-Induced Apoptosis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only